Exercise of options
Faron Pharmaceuticals Ltd. (“Faron”) Exercise of options Issue of equity Company announcement, January 19, 2024, at 1:00 p.m. GMT / 3:00 p.m. EET TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical- stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces that it has received notifications from option holders to exercise 2015B options over 5,000 shares in the Company at an exercise price of EUR 2.90 (approx. GBP 2.48) per share, 2015D options over 8,000 shares in the